Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Authors:
- Laure-Alix ClerbauxLCLaure-Alix Clerbaux
- Maria Cristina AlbertiniMaria Cristina Albertini
- Núria AmigóNANúria Amigó
- Anna BeroniusABAnna Beronius
- Gillina F. G. BezemerGBGillina F. G. Bezemer
- Sandra CoeckeSCSandra Coecke
- Evangelos P. DaskalopoulosEDEvangelos P. Daskalopoulos
- Giusy del GiudiceGGGiusy del Giudice
- Dario GrecoDario Greco
- Lucia GrengaLGLucia Grenga
- Alberto MantovaniAlberto Mantovani
- Amalia MuñozAMAmalia Muñoz
Open Access
- 31 July 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (15) , 4464
Abstract
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows that outcomes are markedly heterogeneous between patients. This requires identifying the factors and understanding how they mechanistically influence COVID-19. Here, we describe how eleven selected factors (age, sex, genetic factors, lipid disorders, heart failure, gut dysbiosis, diet, vitamin D deficiency, air pollution and exposure to chemicals) influence COVID-19 by applying the Adverse Outcome Pathway (AOP), which is well-established in regulatory toxicology. This framework aims to model the sequence of events leading to an adverse health outcome. Several linear AOPs depicting pathways from the binding of the virus to ACE2 up to clinical outcomes observed in COVID-19 have been developed and integrated into a network offering a unique overview of the mechanisms underlying the disease. As SARS-CoV-2 infectibility and ACE2 activity are the major starting points and inflammatory response is central in the development of COVID-19, we evaluated how those eleven intrinsic and extrinsic factors modulate those processes impacting clinical outcomes. Applying this AOP-aligned approach enables the identification of current knowledge gaps orientating for further research and allows to propose biomarkers to identify of high-risk patients. This approach also facilitates expertise synergy from different disciplines to address public health issues.Keywords
All Related Versions
Funding Information
- Research Council of Finland (322761)
- Fundação para a Ciência e a Tecnologia (CEECIND/01049/2020)
This publication has 546 references indexed in Scilit:
- Global association of air pollution and heart failure: a systematic review and meta-analysisThe Lancet, 2013
- Toll like receptor signaling in “inflammaging”: microRNA as new playersImmunity & Ageing, 2013
- Commensal Clostridia: leading players in the maintenance of gut homeostasisGut Pathogens, 2013
- Linking Lipid Metabolism to the Innate Immune Response in Macrophages through Sterol Regulatory Element Binding Protein-1aCell Metabolism, 2011
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Normalization of obesity-associated insulin resistance through immunotherapyNature Medicine, 2009
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut MicrobiomeCell Host & Microbe, 2008
- The Human Microbiome ProjectNature, 2007
- Human gut microbes associated with obesityNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006